Search

More firms target medical cannabis space

A medical cannabis company focused on animal health has announced plans to list on the ASX, while two other companies - including a pearling business - have made movements in the pharmaceutical space.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Source: Morningstar

Total Shareholder Return as at 30/08/19

1 year TSR5 year TSR
91stWhiteHawk75%
331stPearl Global0%-67%
445thZelda Therapeutics-15%34%
662ndPeppermint Innovation-47%-4%
736 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

06/06/19
$301k Sold
06/06/19
$131k Bought
06/06/19
$105k Sold
Total value as at the date of the transaction
Source: Morningstar

Revenue

145th↑Pearl Global$868k
146th-Ocean Grown Abalone$844k
147th↑Zelda Therapeutics$769k
148th↑WhiteHawk$737k
149th↑Peppermint Innovation$710k
197 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer